/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Achieve Life Sciences Inc Share Price Today: Live Updates & Key Insights

Achieve Life Sciences Inc share price today is $6.61, up 1.53%. The stock opened at $6.69 against the previous close of $6.55, with an intraday high of $6.7 and low of $6.5.

Achieve Life Sciences Inc Share Price Chart

style
pb-0

Achieve Life Sciences Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Achieve Life Sciences Inc Share Price Performance

$6.61 0.0153(1.53%) ACHV at 10 Aug 2026 05:49 PM Biotechnology
Lowest Today 6.5
Highest Today 6.7
Today’s Open 6.69
Prev. Close 6.55
52 Week High 7.11
52 Week Low 2.37
Day’s Range: Low 6.5 High 6.7
52-Week Range: Low 2.37 High 7.11
1 day return -
1 Week return +5.22
1 month return +3.74
3 month return +18.66
6 month return +53.46
1 year return +171.22
3 year return +24.67
5 year return -10.56
10 year return -

Achieve Life Sciences Inc Institutional Holdings

Franklin Resources Inc 4.26

Propel Bio Management LLC 3.69

Vanguard Morn Total Stk Mkt Idx Investor 3.03

Vanguard Capital Management, LLC 2.15

iShares Russell 2000 ETF 1.95

Franklin Biotechnology Discv A(acc)USD 1.88

Simplify Asset Management Inc. 1.40

Simplify Propel Opportunities ETF 1.40

State Street® SPDR® S&P® Biotech ETF 1.30

Franklin Biotechnology Discovery A 1.07

Millennium Management LLC 1.05

Marshall Wace Asset Management Ltd 0.99

Vanguard Institutional Extnd Mkt Idx Tr 0.93

LPL Financial Corp 0.71

iShares Russell 2000 Growth ETF 0.70

Nantahala Capital Management, LLC 0.63

Geode Capital Management, LLC 0.61

Two Sigma Investments LLC 0.57

Russell 2000 Equity Index Fund B 0.50

Russell 2000 Index Non-Lendable Fund 0.50

KVP Capital Advisors, LP 0.45

State St Russell Sm/Mid Cp® Indx SL Cl I 0.44

Vanguard Russell 2000 ETF 0.44

BlackRock Inc 0.43

Susquehanna International Group, LLP 0.37

UBS Group AG 0.32

Vanguard Fiduciary Trust Co 0.31

State St Russell Sm Cap® Idx SL Cl I 0.28

Fidelity Enhanced Small Cap Core ETF 0.27

Fidelity Extended Market Index 0.27

iShares Micro-Cap ETF 0.26

State Street Corp 0.25

Northern Trust Corp 0.22

Shay Capital LLC 0.20

683 Capital Management LLC 0.19

BlackRock Extended Equity Market Fund K 0.19

Schwab Small Cap Index 0.18

Jane Street Group LLC 0.17

NT R2000 Index Fund - NL 0.17

Extended Equity Market Fund B 0.15

Achieve Life Sciences Inc Market Status

Strong Buy: 7

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Achieve Life Sciences Inc Fundamentals

Market Cap 672.42 M

PB Ratio 62.2511

PE Ratio 0.0

Enterprise Value 650.40 M

Total Assets 41.79 M

Volume 712555

Achieve Life Sciences Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-35571000 -35.6M, FY22:-41875000 -41.9M, FY21:-32902000 -32.9M, FY20:-14661000 -14.7M, FY19:-16141000 -16.1M

Quarterly Revenue Q1/2026:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M

Quarterly Profit Q1/2026:-57000 -0.1M, Q3/2025:-54000 -0.1M, Q2/2025:-55000 -0.1M, Q1/2025:-62000 -0.1M, Q3/2024:null 0.0M

Quarterly Net worth Q1/2026:-10168000 -10.2M, Q3/2025:-14441000 -14.4M, Q2/2025:-12718000 -12.7M, Q1/2025:-12827000 -12.8M, Q3/2024:-12512000 -12.5M

About Achieve Life Sciences Inc & investment objective

Company Information Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

Organisation Biotechnology

Employees 28

Industry Biotechnology

CEO Dr. Andrew D. Goldberg M.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

Achieve Life Sciences Inc FAQs

What is the share price of Achieve Life Sciences Inc today?

The current share price of Achieve Life Sciences Inc is $6.61.

Can I buy Achieve Life Sciences Inc shares in India?

Yes, Indian investors can buy Achieve Life Sciences Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Achieve Life Sciences Inc shares in India?

You can easily invest in Achieve Life Sciences Inc shares from India by:

Can I buy fractional shares of Achieve Life Sciences Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Achieve Life Sciences Inc?

Achieve Life Sciences Inc has a market cap of $672.42 M.

In which sector does Achieve Life Sciences Inc belong?

Achieve Life Sciences Inc operates in the Biotechnology sector.

What documents are required to invest in Achieve Life Sciences Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Achieve Life Sciences Inc?

The PE ratio of Achieve Life Sciences Inc is N/A and the PB ratio is 62.25.